Background: The objective of the present study was to analyse the demographic, clinicopathological and perioperative outcome of patients undergoing D2 gastrectomy in a high-volume tertiary care hospital in Kashmir a high incidence area.Methods: A total of 89 gastric cancer patients operated in the department of surgical gastroenterology, SKIMS, Kashmir, from January 2018 to December 2021 were included. A standardized D2 lymphadenectomy with spleen/pancreas preservation was performed.Results: Most of the patients in our study were elderly males and the mean age of patients in our series was 60.12±9.4. Majority of the patients in this study had stage III (91%) disease. Nodal involvement (N2, N3) was seen in 66% of patients. The average blood loss during operation was (380.23±48.53 ml) in our patients. The mean number of harvested lymph nodes was (26.6±10.1) with the range of (12-40). Mean operative time was (180±32.58 min). Average hospital stay was (8±2.46 days) in this series.Conclusions: Data from our study suggests that D2-gastrectomy when performed by skilled team in high volume centre like SKIMS is safe and should be the standard of care for gastric cancer for improved outcome.
Background: The aim of this study was to compare the clinical outcomes, survival, morbidity and mortality of D1 and D2 gastrectomy in Kashmiri population in a high-volume tertiary care centre.Methods: Data were collected retrospectively from the prospective database maintained by Department of Surgical Gastroenterology at SKIMS, Kashmir India. We did direct comparison of D1 and D2 gastrectomy in gastric cancer patients who underwent surgery between January 2016 to December 2021 and fulfilled the eligibility criteria. A total of 98 patients were included in the study of which 46 underwent a D1 gastrectomy and 52 underwent a D2 gastrectomy.Results: Male-female ratio was 3:1 in both groups with a mean age of 61 years. There was no significant difference in terms of age or gender between D1 and D2 groups (p>0.05). The mean number of harvested lymph nodes (LN) was (7±1.9) in the D1 group compared to (27.6±10.1) the D2 group (p=0.001). Average hospital stay was comparable in both groups. The median survival was 26 months for the D2 and 19 months for the D1 group (p≤0.01). The survival in the D2 group was significantly higher than in the D1 group. There was no difference in postoperative complications between two groups in our study.Conclusions: our study indicates that D2 gastrectomy should be the standard of treatment for advanced stage II /III disease as it improves the survival outcome in these patients without affecting overall hospital stay, morbidity and mortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.